Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet Syndrome

Kevin M Goff,Ethan M Goldberg,Kevin Mitchell Goff,Ethan Michael Goldberg
DOI: https://doi.org/10.7554/eLife.46846
IF: 7.7
2019-10-08
eLife
Abstract:Dravet Syndrome (DS) is a severe neurodevelopmental disorder caused by pathogenic loss of function variants in the gene SCN1A which encodes the voltage gated sodium (Na+) channel subunit Nav1.1. GABAergic interneurons expressing parvalbumin (PV-INs) and somatostatin (SST-INs) exhibit impaired excitability in DS ( Scn1a +/-) mice. However, the function of a third major class of interneurons in DS – those expressing vasoactive intestinal peptide (VIP-IN) is unknown. We recorded VIP-INs in brain slices from Scn1a +/- mice and wild-type littermate controls and found prominent impairment of irregular spiking (IS), but not continuous adapting (CA) VIP-INs, in Scn1a +/- mice. Application of the Nav1.1-specific toxin Hm1a rescued the observed deficits. The IS vs. CA firing pattern is determined by expression of KCNQ channels; IS VIP-INs switched to tonic firing with both pharmacologic blockade of M-current and muscarinic acetylcholine receptor activation. These results show that VIP-INs express Nav1.1 and are dysfunctional in DS, which may contribute to DS pathogenesis.
biology
What problem does this paper attempt to address?